Waverley Pharma Competitors and Similar CompaniesClear all

Waverley Pharma's competitors and similar companies include Progenics Pharmaceuticals, Biocon and RS Research.

	Waverley Pharma Waverley Pharma is a specialty pharma company developing and commercializing therapeutics that aim to cure generic oncology.	Progenics Pharmaceuticals Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.	Biocon Biocon is a company that develops and manufactures biopharmaceutical products.	RS Research RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy.
Founding Date	Founding Date 2014	Founding Date 1986	Founding Date 1978	Founding Date 2015
Type	Type Public	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Winnipeg, CA HQ	Locations New York, US HQ Billerica, US	Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more	Locations Epalinges, CH HQ
Employees	Employees N/A	Employees 49	Employees 16,5612% increase	Employees 254% decrease
Financial
Revenue (est.)	Revenue (est.) $1.3m (FY, 2025)	Revenue (est.) $35m (FY, 2019)	Revenue (est.) ₹167.8b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods $752k (FY, 2025)	Cost of goods $3.2m (FY, 2019)	Cost of goods ₹56.9b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit $597k (FY, 2025)	Gross profit $31.8m (FY, 2019)	Gross profit ₹115.8b (FY, 2026)	Gross profit N/A
Net income	Net income ($499k) (FY, 2025)	Net income ($68.6m) (FY, 2019)	Net income ₹3.7b (FY, 2026)	Net income N/A